Stock Market News For Nov 12, 2018
AnaptysBio, Inc. ANAB was a big mover last session, as the company saw its shares rise nearly 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $85.41 to $92.80 in the past one-month time frame.
The move came after the company announced plans to offer $200 million of its common stock in an underwritten public offering.
The company’s Zacks Consensus Estimate for the current quarter has moved lower over the past few weeks, suggesting there may be trouble down the road. So, make sure to keep an eye on this stock going forward, to see if this recent move higher can last.
AnaptysBio currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
AnaptysBio, Inc. Price
AnaptysBio, Inc. Price | AnaptysBio, Inc. Quote
Investors interested in the Medical - Biomedical and Genetics industry may consider Illumina, Inc. ILMN, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is ANAB going up? Or down? Predict to see what others think:Up or Down
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Illumina, Inc. (ILMN) : Free Stock Analysis Report
AnaptysBio, Inc. (ANAB) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research